Moderna's mRNA flu shot earns FDA approval after rollercoaster review

Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up. https://arstechnica.com/health/2026/08/modernas-mrna-flu-shot-earns-fda-approval-after-rollercoaster-review/?utm_brand=arstechnica&utm_social-type=owned&utm_source=mastodon&utm_medium=social